Rush-Presbyterian-St. Luke's Medical Center in Chicago will receive the first commercial shipment of Acuson's AcuNav diagnostic ultrasound catheter, which was cleared for market by the FDA at the end of last year. The intracardiac ultrasound
Rush-Presbyterian-St. Luke's Medical Center in Chicago will receive the first commercial shipment of Acuson's AcuNav diagnostic ultrasound catheter, which was cleared for market by the FDA at the end of last year.
The intracardiac ultrasound technique works by inserting a catheter through the patient's femoral or jugular vein. Clinicians can then maneuver it into the right atrium or right ventricle of the heart. The catheter uses color Doppler to image blood flow.
Dr. Richard Trohman of Rush-Presbyterian-St. Luke's said the catheter will allow electrophysiologists to perform procedures they were previously unable to do, because the AcuNav images the heart from within. An Acuson Sequoia ultrasound system is also part of the purchase.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
2 Commerce Drive
Cranbury, NJ 08512